Pregnancy Contraindication Removed From Copaxone
Pregnancy contraindication removed from Copaxone 40mg/ml 3-times weekly, the first drug in this category to be cleared; Positive report agreed at European level, approval granted by Irish regulator Approximately 9,000 people in Ireland have multiple sclerosis, an autoimmune disease of the nervous system that disproportionately affects women of childbearing age